The company will respond to the CRL to satisfy the FDA’s requests
read the full story about USFDA rejects Biocon, Viatris application for Insulin Aspart
#theheadlines #breakingnews #headlinenews #newstoday #latestnews #aajtak #ndtv #timesofindia #indiannews